Hydase is a Infiltration; Interstitial; Intramuscular; Intraocular; Retrobulbar; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Akorn, Inc.. The primary component is Hyaluronidase.
| Product ID | 17478-560_d0aefc9f-b2fb-4490-8642-c5a70f0a4a54 |
| NDC | 17478-560 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Hydase |
| Generic Name | Hyaluronidase |
| Dosage Form | Injection, Solution |
| Route of Administration | INFILTRATION; INTERSTITIAL; INTRAMUSCULAR; INTRAOCULAR; RETROBULBAR; SUBCUTANEOUS |
| Marketing Start Date | 2015-11-05 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021716 |
| Labeler Name | Akorn, Inc. |
| Substance Name | HYALURONIDASE |
| Active Ingredient Strength | 150 [USP'U]/mL |
| Pharm Classes | Endoglycosidase [EPC],Glycoside Hydrolases [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2015-11-05 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | BLA |
| Application Number | BLA021716 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2015-11-05 |
| Marketing End Date | 2015-12-01 |
| Marketing Category | BLA |
| Application Number | BLA021716 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2015-11-05 |
| Marketing End Date | 2015-12-01 |
| Marketing Category | BLA |
| Application Number | BLA021716 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2015-11-05 |
| Marketing End Date | 2015-12-01 |
| Ingredient | Strength |
|---|---|
| HYALURONIDASE | 150 [USP'U]/mL |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 17478-560 | Hydase | Hyaluronidase |
| 0548-9090 | AMPHADASE | hyaluronidase |
| 51662-1555 | HYALURONIDASE | HYALURONIDASE |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() HYDASE 86813398 not registered Dead/Abandoned |
Akorn, Inc. 2015-11-09 |
![]() HYDASE 76330151 not registered Dead/Abandoned |
Purified Proteins, Inc. 2001-10-26 |